Abstract

A study conducted by Deerland Probiotics has shown promising results on the effectiveness of the probiotic ingredient Bacillus subtilis DE111. Specifically, in a trial of 44 adults between the ages of 20 and 62 with a 4-week supplementation period, these participants showed immunomodulatory and anti-inflammatory effects on various subsets of T cells.